Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
22.74
+0.04 (0.18%)
May 8, 2026, 3:00 PM CST

SHA:600332 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
12,32814,94018,27321,30922,50022,377
Short-Term Investments
-8,8614,446729.162,117-
Trading Asset Securities
44-456.87-
Cash & Short-Term Investments
12,33223,80522,71922,04224,67322,377
Cash Growth
-33.49%4.78%3.07%-10.66%10.26%14.61%
Accounts Receivable
25,68020,94019,45619,59819,16817,211
Other Receivables
1,3581,186993.65882.35920.511,276
Receivables
27,03822,12620,44920,48020,08818,486
Inventory
12,46913,13812,81211,50710,67210,438
Other Current Assets
13,2272,4491,7821,9551,6311,510
Total Current Assets
65,06561,51857,76255,98457,06452,811
Property, Plant & Equipment
8,4428,3657,9397,5166,5705,684
Long-Term Investments
10,3718,79310,1469,4525,8972,891
Goodwill
919.94834.09830.85829.47829.47829.47
Other Intangible Assets
3,1723,1812,8292,8862,5852,582
Long-Term Deferred Tax Assets
1,2551,2861,2101,164865.34794.23
Long-Term Deferred Charges
155.82162.47558.49499.77407.47143.05
Other Long-Term Assets
377.55370.9407.77256.22446.54382.46
Total Assets
89,75884,51181,68478,58774,66566,118
Accounts Payable
18,28317,57116,32015,68614,96114,733
Accrued Expenses
770.643,5693,6733,6513,4843,478
Short-Term Debt
11,8159,8609,1237,7999,1468,428
Current Portion of Long-Term Debt
1,4072,0271,33236.45498.5830.03
Current Portion of Leases
-185.2190.57213.38208.15215.77
Current Income Taxes Payable
561.66170.9118.4249.26237143.41
Current Unearned Revenue
1,2972,8335,0725,4305,6442,740
Other Current Liabilities
6,6292,9093,0883,1703,2162,485
Total Current Liabilities
40,76339,12538,91636,23537,39532,254
Long-Term Debt
4,8593,1742,8063,3241,639752.81
Long-Term Leases
367.01371.47445.72578.19545.84497.7
Long-Term Unearned Revenue
1,0821,0421,0021,001930.93826.86
Pension & Post-Retirement Benefits
0.290.290.30.290.320.3
Long-Term Deferred Tax Liabilities
598.33599.37625.56639.53394.59331.73
Other Long-Term Liabilities
194.41116.74119.31130.6121.45127.87
Total Liabilities
47,86544,42843,91441,90941,02734,791
Common Stock
1,6261,6261,6261,6261,6261,626
Additional Paid-In Capital
10,32410,32410,11410,10610,1069,957
Retained Earnings
27,64525,86124,17923,21220,34717,497
Comprehensive Income & Other
-33.34-22.6-13.84-24.34-12.9-17.48
Total Common Equity
39,56137,78835,90534,91932,06529,062
Minority Interest
2,3322,2951,8651,7591,5732,264
Shareholders' Equity
41,89340,08337,77036,67833,63831,327
Total Liabilities & Equity
89,75884,51181,68478,58774,66566,118
Total Debt
18,44815,61713,89711,95112,0389,924
Net Cash (Debt)
-6,1178,1888,82310,09112,63512,453
Net Cash Growth
--7.20%-12.57%-20.14%1.47%24.99%
Net Cash Per Share
-3.765.045.436.217.777.66
Filing Date Shares Outstanding
1,6261,6261,6261,6261,6261,626
Total Common Shares Outstanding
1,6261,6261,6261,6261,6261,626
Working Capital
24,30222,39418,84719,74819,66920,557
Book Value Per Share
24.3323.2422.0821.4819.7217.88
Tangible Book Value
35,46933,77332,24531,20328,65125,650
Tangible Book Value Per Share
21.8220.7719.8319.1917.6215.78
Buildings
-6,4645,2134,3283,6303,317
Machinery
-5,5215,1064,4164,0253,582
Construction In Progress
-1,1501,8462,4052,1081,564
Source: S&P Global Market Intelligence. Standard template. Financial Sources.